Pharmaceutical News and Articles

Comprehensive and up-to-date drug news for both consumers and healthcare professionals.

Climate Change Tied to Alterations in Pollen Seasons, Concentrations

Climate change seems to be altering pollen seasons and concentrations, potentially impacting allergic rhinitis, according to a review published online April 9 i

Medical Complexity Seen in 12 Percent of Military-Connected Children

The cumulative incidence of children with medical complexity (CMC)-defining diagnoses in military-connected children is 12.0 percent by age 60 months, according

Seasonal Allergies Likely To Grow Worse Under Climate Change

Spring is officially here, and with it comes watery eyes, stuffy noses and constant sneezing for people with seasonal allergies.And climate change means things

Half-Million Children Could Die If U.S. AIDS Relief Is Dropped

FRIDAY, April 11, 2025 Nearly a half-million children could die from AIDS by 2030 if President Donald Trump follows through on plans to cut U.S. relief programs

New Visual Test For Autism Could Aid Earlier Diagnosis

How children respond to movement could provide an early means of detecting autism, a new study says.Children with autism are known to prefer watching repetitive

Most Women Aren't Clear When Menopause Might Start

Early symptoms of menopause will first appear when many women least expect them, a new Ohio State University poll reports.Hot flashes, mood swings, weight gain

Showerhead Water Limits Rescinded as Trump Targets Household Appliances

FRIDAY, April 11, 2025 President Donald Trump signed an order this week removing limits on how much water can come out of showerheads. He said the change will h

Icotrokinra Results Show 75% of Adolescents with Plaque Psoriasis Achieved Completely Clear Skin and Demonstrate Favorable Safety Profile in a Once Daily Pill

SPRING HOUSE, Pa. (April 10, 2025) Johnson Johnson (NYSE JNJ) today announced new icotrokinra (JNJ-2113) data from a subgroup analysis of ICONIC-LEADa, the firs

Tolebrutinib Phase 3 Data Published in NEJM Demonstrate Benefit on Disability Progression in Multiple Sclerosis

Paris, April 8, 2025. The New England Journal of Medicine (NEJM) published positive results from the HERCULES phase 3 study demonstrating that tolebrutinib dela

FDA Announces Plan to Phase Out Animal Testing Requirement for Monoclonal Antibodies and Other Drugs

Today, the U.S. Food and Drug Administration is taking a groundbreaking step to advance public health by replacing animal testing in the development of monoclon

Popular Keywords